# Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole

> **NCT02190708** · PHASE1 · COMPLETED · sponsor: **Vivoryon Therapeutics N.V.** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers
- Pharmacologic Action

## Interventions

- **DRUG:** PQ912
- **DRUG:** Midazolam
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT02190708
- **Lead sponsor:** Vivoryon Therapeutics N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02190708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02190708, "Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02190708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*